Posted to Announcement on 6/21/2010 at 10:20 AM
CSL Behring in King of Prussia, PA - www.cslbehring.com - has entered into an agreement with ProFibrix B.V., which is headquartered in Leiden, the Netherlands and has a subsidiary in Seattle, to supply plasma-based fibrinogen and thrombin, which are blood-clotting proteins. ProFibrix will use the proteins, which CSL Behring extracts from blood plasma, to make an innovative topical tissue sealant for use during and after surgery to stop bleeding.
CSL Behring is a leader in the plasma protein therapeutics industry. The company develops and manufactures plasma-derived and recombinant therapies for people with rare and serious diseases.
Related Link: Click to View
Share This Post With Others